Navigation Links
Age at first menstrual cycle, menopause tied to heart disease risk
Date:3/7/2013

Chevy Chase, MD Chinese women are less likely to develop cardiovascular disease if they have their first menstrual cycle or enter menopause later than their peers, according to a recent study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism (JCEM).

The study also found earlier onset of menopause was associated with a higher risk of developing osteoporosis. The risk was significantly lower for women who were older than 50 when they underwent menopause. The findings could be used to identify women who are more likely to face heart disease or osteoporosis.

"Determining who is at risk for these conditions may aid health care professionals in preventing and detecting cardiovascular disease and osteoporosis," said the study's lead author, Gang Chen, M.D., Ph.D., of Fujian Medical University in China.

Women who were 18 or older when they had their first menstrual cycle had a lower risk of developing cardiovascular disease, according to the analysis. Previous studies have found that earlier onset of the first menstrual cycle (menarche) is associated with increased body mass index and waist circumference, which may partly explain the findings.

Although the links between cardiovascular health and age at the onset of menarche and menopause have been researched in western countries, this study was among the first to examine whether the same associations exist in an Asian population. The cross-sectional population study evaluated 3,304 post-menopausal women in southeastern China's Fujian Province.

"Our study examined the age at menarche and menopause of Chinese women to see what we could learn about their disease risk," Chen said. "The findings provide valuable insights about who is at risk and will benefit future efforts to improve heart and bone health."


'/>"/>

Contact: Jenni Glenn Gingery
jgingery@endo-society.org
301-941-0240
The Endocrine Society
Source:Eurekalert

Page: 1

Related biology news :

1. Genetic signs of alcoholism in women studied for the first time
2. Synthetic molecule first electricity-making catalyst to use iron to split hydrogen gas
3. Spectacular forcepfly species discovered for the first time in South America
4. World first for fly research
5. PeerJ publishes its first articles
6. First-in-man study demonstrates the therapeutic effect of RNAi gene silencing in cancer treatment
7. Animal magnetism: First evidence that magnetism helps salmon find home
8. Joslin scientists find first human iPSC from patients with maturity onset diabetes of the young
9. U. of Minn. researchers unveil first artificial enzyme created by evolution in a test tube
10. Study of human specimen collections in the US offers first look at their huge diversity
11. Canada launches first gene therapy trial for Fabry disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... -- First quarter 2016:   , Revenues ... first quarter of 2015 The gross margin was 49% ... and the operating margin was 40% (-13) Earnings per ... from operations was SEK 249.9 M (21.2) , Outlook ... 7,000-8,500 M. The operating margin for 2016 is estimated ...
(Date:4/15/2016)... -- Research and Markets has announced the ...  report to their offering.  ,      ... gait biometrics market is expected to grow at ... Gait analysis generates multiple variables such ... compute factors that are not or cannot be ...
(Date:3/29/2016)... Florida , March 29, 2016 ... the "Company") LegacyXChange "LEGX" and SelectaDNA/CSI Protect are pleased ... in ink used in a variety of writing instruments, ... Buyers of originally created collectibles from athletes on LegacyXChange ... forensic analysis of the DNA. Bill ...
Breaking Biology News(10 mins):
(Date:6/24/2016)... Brooklyn, NY (PRWEB) , ... June 24, 2016 , ... ... 15mm, machines such as the Cary 5000 and the 6000i models are higher end ... height is the height of the spectrophotometer’s light beam from the bottom of the ...
(Date:6/23/2016)... , June 23, 2016 /PRNewswire/ - FACIT ... Ontario biotechnology company, Propellon Therapeutics ... development and commercialization of a portfolio of first-in-class ... Epigenetic targets such as WDR5 represent an exciting ... significantly in precision medicine for cancer patients. Substantial ...
(Date:6/23/2016)... June, 23, 2016  The Biodesign Challenge (BDC), a ... ways to harness living systems and biotechnology, announced its ... in New York City . ... students, showcased projects at MoMA,s Celeste Bartos Theater during ... , MoMA,s senior curator of architecture and design, and ...
(Date:6/23/2016)... 2016 Apellis Pharmaceuticals, Inc. today announced ... of its complement C3 inhibitor, APL-2. The trials ... dose studies designed to assess the safety, tolerability, ... in healthy adult volunteers. Forty subjects ... single dose (ranging from 45 to 1,440mg) or ...
Breaking Biology Technology: